2021
DOI: 10.1007/s13346-021-01094-2
|View full text |Cite
|
Sign up to set email alerts
|

EGFR-targeted pemetrexed therapy of malignant pleural mesothelioma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 34 publications
0
2
0
Order By: Relevance
“…The cRGD peptide facilitated penetration of these polymersomes to a depth of 200 μm within microtumor stem cells . Dual roles of the GE11 peptide in targeting MSTO-211H lung tumors and markedly increased tumor penetration of epidermal growth factor receptor-chimaeric polymersomes-pemetrexed (EGFR-CPs-PEM) was also reported . In another study, selective cell targeting, penetrating, and retention properties were imparted to reduction sensitive polymersomes by the CPP33 peptide for protein delivery .…”
Section: Active Targetingmentioning
confidence: 90%
See 1 more Smart Citation
“…The cRGD peptide facilitated penetration of these polymersomes to a depth of 200 μm within microtumor stem cells . Dual roles of the GE11 peptide in targeting MSTO-211H lung tumors and markedly increased tumor penetration of epidermal growth factor receptor-chimaeric polymersomes-pemetrexed (EGFR-CPs-PEM) was also reported . In another study, selective cell targeting, penetrating, and retention properties were imparted to reduction sensitive polymersomes by the CPP33 peptide for protein delivery .…”
Section: Active Targetingmentioning
confidence: 90%
“…39,40 41 Dual roles of the GE11 peptide in targeting MSTO-211H lung tumors and markedly increased tumor penetration of epidermal growth factor receptor-chimaeric polymersomes-pemetrexed (EGFR-CPs-PEM) was also reported. 42 In another study, selective cell targeting, penetrating, and retention properties were imparted to reduction sensitive polymersomes by the CPP33 peptide for protein delivery. 43 Moreover, Oz et al 44 used a type of breast cancer homing peptide, Peptide (18), to target integrin receptors for in vitro Doxorubicin (DOX) delivery.…”
Section: Active Targetingmentioning
confidence: 99%